Search
for
Sort by
Research 91–120 of 1000+
- Androgen Receptor in Human Health: A Potential Therapeutic Target
- Extraskeletal actions of vitamin D
- The PDGF/PDGFR pathway as a drug target
- Androgen Receptor Ligands: Agonists and Antagonists
- Targeting the Wnt pathways for therapies
- Is polycystic ovary syndrome a sexual conflict? A review
- Perspectives in dermatopathology: telomeres and telomerase in ageing and cancer; with emphasis on cutaneous disease
- Clinical Development of Topoisomerase-Interactive Drugs
- Indian Gooseberry (<i>Emblica officinalis</i>Gaertn.)
- Angelica gigas Nakai (Korean Dang-gui) Root Alcoholic Extracts in Health Promotion and Disease Therapy – active Phytochemicals and In Vivo Molecular Targets
- Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells
- Roles of Wnt7a in embryo development, tissue homeostasis, and human diseases
- Melatonin-Loaded Nanocarriers: New Horizons for Therapeutic Applications
- Simultaneous quantitation of nine hydroxy-androgens and their conjugates in human serum by stable isotope dilution liquid chromatography electrospray ionization tandem mass spectrometry
- Anabolic androgenic steroids and carcinogenicity focusing on Leydig cell: a literature review
- The molecular pathogenesis of Trichilemmal carcinoma
- Synopsis: 2005 Annual Meeting of the American Society of Andrology
- Telocytes of the male reproductive system: dynamic tissue organizers
- TRP Channels in Skin Biology and Pathophysiology
- New insights into the role of Runx1 in epithelial stem cell biology and pathology
- Keratinocyte-Specific Onset of Serine Protease BSSP Expression in Experimental Carcinogenesis
- S100A6 Protein—Expression and Function in Norm and Pathology
- Organoid‐Guided Precision Medicine: From Bench to Bedside
- Perspective Chapter: Appraisal of Paclitaxel (Taxol) Pros and Cons in the Management of Cancer – Prospects in Drug Repurposing
- The role of fibroblast growth factor receptor 2b in skin homeostasis and cancer development
- Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI)
- Triple Hormonal Blockade (ADT3): A Patient’s Perspective
- Folate receptor β performs an immune checkpoint function in activated macrophages
- Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours
- Pilomatricoma in Syndromic Contexts: A Literature Review and a Report of a Case in Apert Syndrome